Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Reexamination Certificate
2007-09-25
2007-09-25
Hartley, Michael G. (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Reexamination Certificate
active
10831626
ABSTRACT:
2′-Deoxy-2′-[18F]-labeled and 3′-deoxy-3′-[18F]-labeled purine nucleoside analogs such as [18F]-FAA and [18F]-FXA have been found to have desirable properties for use as imaging agents. The analogs are particularly useful for in vivo imaging of biological material including organ tissues (e.g., heart, liver, brain and kidneys) and tumors. Methods for the preparation of the [18F]-FAA and [18F]-FXA are also provided.
REFERENCES:
patent: 4751221 (1988-06-01), Watanabe et al.
patent: 5879661 (1999-03-01), Conti et al.
patent: 5959100 (1999-09-01), Kirschenheuter et al.
patent: 2002/0061279 (2002-05-01), DeGrado et al.
Van Den Boogaart et al. Eur. J. Biochem. 1994, 221, 759-768.
Alauddin Mian M.
Conti Peter S.
Fissekis John D.
Hartley Michael G.
Hogan & Hartson LLP
Perreira Melissa
University of Southern California
LandOfFree
[18F]-furanosylpurine derivatives and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with [18F]-furanosylpurine derivatives and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and [18F]-furanosylpurine derivatives and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3728864